• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发现(5-苯基呋喃-2-基)甲胺衍生物作为新型人 Sirtuin 2 抑制剂。

Discovery of (5-Phenylfuran-2-yl)methanamine Derivatives as New Human Sirtuin 2 Inhibitors.

机构信息

College of Food and Bioengineering, Xihua University, Sichuan 610039, China.

College of Science, Xihua University, Sichuan 610039, China.

出版信息

Molecules. 2019 Jul 26;24(15):2724. doi: 10.3390/molecules24152724.

DOI:10.3390/molecules24152724
PMID:31357491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6695594/
Abstract

Human sirtuin 2 (SIRT2), a member of the sirtuin family, has been considered as a promising drug target in cancer, neurodegenerative diseases, type II diabetes, and bacterial infections. Thus, SIRT2 inhibitors have been involved in effective treatment strategies for related diseases. Using previously established fluorescence-based assays for SIRT2 activity tests, the authors screened their in-house database and identified a compound, 4-(5-((3-(quinolin-5-yl)ureido)methyl)furan-2-yl)benzoic acid (), which displayed 63 ± 5% and 35 ± 3% inhibition against SIRT2 at 100 μM and 10 μM, respectively. The structure-activity relationship (SAR) analyses of a series of synthesized (5-phenylfuran-2-yl)methanamine derivatives led to the identification of a potent compound with an IC value of 2.47 μM, which is more potent than AGK2 (IC = 17.75 μM). Meanwhile, likely possesses better water solubility (cLogP = 1.63 and cLogS = -3.63). Finally, the molecular docking analyses indicated that fitted well with the induced hydrophobic pocket of SIRT2.

摘要

人源 sirtuin 2(SIRT2)作为 sirtuin 家族的一员,被认为是癌症、神经退行性疾病、2 型糖尿病和细菌感染等相关疾病的一个很有前途的药物靶点。因此,SIRT2 抑制剂已经被应用于相关疾病的有效治疗策略中。本研究作者利用先前建立的基于荧光的 SIRT2 活性测试方法,从他们的内部数据库中筛选出一种化合物,4-(5-((3-(喹啉-5-基)脲基)甲基)呋喃-2-基)苯甲酸(),其在 100 μM 和 10 μM 时对 SIRT2 的抑制率分别为 63 ± 5%和 35 ± 3%。一系列合成的(5-苯基呋喃-2-基)甲胺衍生物的构效关系(SAR)分析,确定了一种强效化合物,其 IC 值为 2.47 μM,比 AGK2(IC = 17.75 μM)更有效。同时,化合物可能具有更好的水溶性(cLogP = 1.63,cLogS = -3.63)。最后,分子对接分析表明,化合物与 SIRT2 的诱导疏水性口袋契合良好。

相似文献

1
Discovery of (5-Phenylfuran-2-yl)methanamine Derivatives as New Human Sirtuin 2 Inhibitors.发现(5-苯基呋喃-2-基)甲胺衍生物作为新型人 Sirtuin 2 抑制剂。
Molecules. 2019 Jul 26;24(15):2724. doi: 10.3390/molecules24152724.
2
Discovery of 2-((4,6-dimethylpyrimidin-2-yl)thio)-N-phenylacetamide derivatives as new potent and selective human sirtuin 2 inhibitors.发现 2-((4,6-二甲基嘧啶-2-基)硫代)-N-苯基乙酰胺衍生物作为新型强效和选择性的人 SIRT2 抑制剂。
Eur J Med Chem. 2017 Jul 7;134:230-241. doi: 10.1016/j.ejmech.2017.04.010. Epub 2017 Apr 12.
3
Discovery of New SIRT2 Inhibitors by Utilizing a Consensus Docking/Scoring Strategy and Structure-Activity Relationship Analysis.利用共识对接/评分策略和构效关系分析发现新型 SIRT2 抑制剂。
J Chem Inf Model. 2017 Apr 24;57(4):669-679. doi: 10.1021/acs.jcim.6b00714. Epub 2017 Mar 28.
4
Pharmacophore modeling and virtual screening studies to identify novel selective SIRT2 inhibitors.用于鉴定新型选择性SIRT2抑制剂的药效团建模和虚拟筛选研究
J Mol Graph Model. 2019 Jun;89:60-73. doi: 10.1016/j.jmgm.2019.02.014. Epub 2019 Mar 5.
5
X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells.X 射线晶体结构指导发现新型选择性、底物模拟的 SIRT2 抑制剂,对非小细胞肺癌细胞具有活性。
Eur J Med Chem. 2018 Jul 15;155:806-823. doi: 10.1016/j.ejmech.2018.06.041. Epub 2018 Jun 19.
6
2-(Methyl(phenyl)amino)-N-(phenyloxyphenyl)acetamide structural motif representing a framework for selective SIRT2 inhibition.代表 SIRT2 选择性抑制结构基序的 2-(甲基(苯基)氨基)-N-(苯氧基苯基)乙酰胺。
Drug Dev Res. 2024 Jun;85(4):e22224. doi: 10.1002/ddr.22224.
7
Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.具有苯甲酰胺骨架的新型沉默调节蛋白2(SIRT2)抑制剂的设计、合成及构效关系研究
Bioorg Med Chem. 2015 Jan 15;23(2):328-39. doi: 10.1016/j.bmc.2014.11.027. Epub 2014 Dec 2.
8
Design, synthesis, in-vitro evaluation and molecular docking studies of novel indole derivatives as inhibitors of SIRT1 and SIRT2.设计、合成、体外评价及新型吲哚衍生物作为 SIRT1 和 SIRT2 抑制剂的分子对接研究。
Bioorg Chem. 2019 Nov;92:103281. doi: 10.1016/j.bioorg.2019.103281. Epub 2019 Sep 16.
9
Identification of inhibitor binding site in human sirtuin 2 using molecular docking and dynamics simulations.使用分子对接和动力学模拟鉴定人源 sirtuin 2 的抑制剂结合位点。
PLoS One. 2013;8(1):e51429. doi: 10.1371/journal.pone.0051429. Epub 2013 Jan 28.
10
The discovery of a highly selective 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one SIRT2 inhibitor that is neuroprotective in an in vitro Parkinson's disease model.一种高度选择性的5,6,7,8-四氢苯并[4,5]噻吩并[2,3-d]嘧啶-4(3H)-酮SIRT2抑制剂的发现,该抑制剂在体外帕金森病模型中具有神经保护作用。
ChemMedChem. 2015 Jan;10(1):69-82. doi: 10.1002/cmdc.201402431. Epub 2014 Nov 13.

引用本文的文献

1
Virtual Screening Combined with Enzymatic Assays to Guide the Discovery of Novel SIRT2 Inhibitors.虚拟筛选结合酶活性测定指导新型 SIRT2 抑制剂的发现。
Int J Mol Sci. 2023 May 27;24(11):9363. doi: 10.3390/ijms24119363.
2
Recent advances in the development of histone deacylase SIRT2 inhibitors.组蛋白脱乙酰酶SIRT2抑制剂开发的最新进展。
RSC Adv. 2020 Oct 9;10(61):37382-37390. doi: 10.1039/d0ra06316a. eCollection 2020 Oct 7.

本文引用的文献

1
Crystallographic and SAR analyses reveal the high requirements needed to selectively and potently inhibit SIRT2 deacetylase and decanoylase.晶体学和构效关系分析揭示了选择性且强效抑制SIRT2去乙酰化酶和癸酰化酶所需的高要求。
Medchemcomm. 2018 Dec 7;10(1):164-168. doi: 10.1039/c8md00462e. eCollection 2019 Jan 1.
2
An overview of Sirtuins as potential therapeutic target: Structure, function and modulators.Sirtuins 作为潜在治疗靶点的概述:结构、功能和调节剂。
Eur J Med Chem. 2019 Jan 1;161:48-77. doi: 10.1016/j.ejmech.2018.10.028. Epub 2018 Oct 15.
3
X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells.
X 射线晶体结构指导发现新型选择性、底物模拟的 SIRT2 抑制剂,对非小细胞肺癌细胞具有活性。
Eur J Med Chem. 2018 Jul 15;155:806-823. doi: 10.1016/j.ejmech.2018.06.041. Epub 2018 Jun 19.
4
Structure-based design and biological evaluation of inhibitors of the pseudomonas aeruginosa heme oxygenase (pa-HemO).基于结构的铜绿假单胞菌血红素加氧酶(pa-HemO)抑制剂的设计与生物学评价
Bioorg Med Chem Lett. 2018 Apr 1;28(6):1024-1029. doi: 10.1016/j.bmcl.2018.02.027. Epub 2018 Feb 14.
5
Synthesis and Evaluation of Novel Benzofuran Derivatives as Selective SIRT2 Inhibitors.新型苯并呋喃衍生物的合成与评价及其作为选择性 SIRT2 抑制剂的研究。
Molecules. 2017 Aug 14;22(8):1348. doi: 10.3390/molecules22081348.
6
Structure-based discovery of new selective small-molecule sirtuin 5 inhibitors.基于结构的新型选择性小分子 SIRT5 抑制剂的发现。
Chem Biol Drug Des. 2018 Jan;91(1):257-268. doi: 10.1111/cbdd.13077. Epub 2017 Aug 18.
7
Discovery of 2-((4,6-dimethylpyrimidin-2-yl)thio)-N-phenylacetamide derivatives as new potent and selective human sirtuin 2 inhibitors.发现 2-((4,6-二甲基嘧啶-2-基)硫代)-N-苯基乙酰胺衍生物作为新型强效和选择性的人 SIRT2 抑制剂。
Eur J Med Chem. 2017 Jul 7;134:230-241. doi: 10.1016/j.ejmech.2017.04.010. Epub 2017 Apr 12.
8
Discovery of New SIRT2 Inhibitors by Utilizing a Consensus Docking/Scoring Strategy and Structure-Activity Relationship Analysis.利用共识对接/评分策略和构效关系分析发现新型 SIRT2 抑制剂。
J Chem Inf Model. 2017 Apr 24;57(4):669-679. doi: 10.1021/acs.jcim.6b00714. Epub 2017 Mar 28.
9
Sirtuin 5: a review of structure, known inhibitors and clues for developing new inhibitors.Sirtuin 5:结构综述、已知抑制剂及开发新型抑制剂的线索。
Sci China Life Sci. 2017 Mar;60(3):249-256. doi: 10.1007/s11427-016-0060-7. Epub 2016 Nov 17.
10
A Continuous, Fluorogenic Sirtuin 2 Deacylase Assay: Substrate Screening and Inhibitor Evaluation.一种连续的、荧光性的沉默调节蛋白2去乙酰化酶检测方法:底物筛选与抑制剂评估。
J Med Chem. 2016 Feb 11;59(3):1021-31. doi: 10.1021/acs.jmedchem.5b01532. Epub 2016 Jan 20.